Targeted Radionuclide Therapy for Autoimmune Diseases Using Lu-177-DOTATATE

This is an original clinical research proposal aiming to treat autoimmune diseases using Lu-177-DOTATATE to selectively target activated lymphocytes.

Publication Details

Journal
OSF Preprints (OSF Preprints)
Published
2025-01-01
DOI
https://doi.org/10.17605/osf.io/7a9zh
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeted Radionuclide Therapy for Autoimmune Diseases Using Lu-177-DOTATATE

OSF Preprints (OSF Preprints)
Radiopharmaceutical Chemistry and Applications
article

Targeted Radionuclide Therapy for Autoimmune Diseases Using Lu-177-DOTATATE

article en

Abstract

This is an original clinical research proposal aiming to treat autoimmune diseases using Lu-177-DOTATATE to selectively target activated lymphocytes.

OSF Preprints (OSF Preprints)
Good health and well-being
Openalex Percentile: Top 39%
Radiopharmaceutical Chemistry and Applications
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Targeted Radionuclide Therapy for Autoimmune Diseases Using Lu-177-DOTATATE · OSF Preprints (OSF Preprints) (2025) | TGRS Research Map | TGRS